MENU
NEWSLETTERS
MENU
SECTIONS
OTHER
CLASSIFIEDS
CONTACT US / FAQ
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Bayer

< Previous 1 2 3 4 5 6 7 8 9 Next >
News headline image
Bayer Introduces Iberogast™ in the U.S., Bringing Proven Plant-Based Relief to the Millions Who Experience Gut Health Issues
From Bayer
Via Business Wire
News headline image
Bayer and Hologic Collaborating to Deliver Contrast-Enhanced Mammography
From Bayer
Via Business Wire
News headline image
Bayer and Google Cloud to accelerate development of AI-powered healthcare applications for radiologists
From Bayer
Via Business Wire
News headline image
Bayer’s Consumer Health Division Announces Changes to North America Leadership Team
From Bayer
Via Business Wire
News headline image
Bayer Appoints Sue Ann Pentecost as Vice President, Head of U.S. Pharmaceutical Communications
From Bayer
Via Business Wire
News headline image
Aleve® Speaks The Painful Truth, Encouraging Consumers to Explore Their Pain Management Options
From Bayer
Via Business Wire
News headline image
Bayer and Thermo Fisher Scientific Collaborate to Increase Patient Access to Precision Cancer Medicines
From Bayer
Via Business Wire
News headline image
Bayer Pharmaceuticals streamlines Leadership Team for next phase of growth
From Bayer
Via Business Wire
News headline image
Positive topline results from Phase III long-term study OASIS 3 support submissions for marketing authorization for Bayer’s elinzanetant
From Bayer
Via Business Wire
News headline image
Bayer Wins Third Consecutive Trial Victory
From Bayer
Via Business Wire
News headline image
Bayer Receives U.S. FDA Breakthrough Therapy Designation for BAY 2927088 for Non-Small Cell Lung Cancer Harboring HER2 Activating Mutations
From Bayer
Via Business Wire
News headline image
Bayer initiates Phase II study with first-in-class anti-alpha2 antiplasmin antibody in patients with deep vein thrombosis
From Bayer
Via Business Wire
News headline image
First Patient Randomized in AskBio Phase II Gene Therapy Trial for Congestive Heart Failure
From Bayer
Via Business Wire
News headline image
Bayer Unveils Groundbreaking Solar Energy Projects at Sites in New Jersey and California
From Bayer
Via Business Wire
News headline image
Bayer appoints Nelson Ambrogio as new Head of Radiology Business at Pharmaceuticals Division
From Bayer
Via Business Wire
News headline image
MiraLAX® Exposes The Gut Gap™, Proving Women are More Stressed and More Constipated than Men
From Bayer
Via Business Wire
News headline image
Bayer Reveals Latest Prostate Cancer Data at 2024 ASCO GU Cancers Symposium
From Bayer
Via Business Wire
News headline image
Bayer starts Phase II study NIRVANA to evaluate elinzanetant in women with sleep disturbances associated with menopause
From Bayer
Via Business Wire
News headline image
Bayer’s elinzanetant meets all primary and key secondary endpoints in pivotal OASIS 1 and 2 Phase III studies
From Bayer
Via Business Wire
News headline image
Bayer Statement on Win in Jones Roundup™ Trial
From Bayer
Via Business Wire
News headline image
Bayer and Salus Optima Partner on AI-Enabled Healthy Aging Journey
From Bayer
Via Business Wire
News headline image
Bayer Earns Top Score in Human Rights Campaign Foundation’s 2023-2024 Corporate Equality Index for Sixth Consecutive Year
From Bayer
Via Business Wire
News headline image
Bayer and CrossBay Medical to develop novel Intrauterine System Inserter
From Bayer
Via Business Wire
News headline image
Bayer and Hurdle launch precision health strategic partnership
From Bayer
Via Business Wire
News headline image
Bayer Announces Publication of Health Economic Model Evaluation at RSNA, Providing New Insights Into Cost Effectiveness and Capacity Needs of Supplemental Screening Modalities for Dense Breasts
From Bayer
Via Business Wire
News headline image
Bayer Championing Advancements in Radiology Pipeline and Accelerating AI Innovation
From Bayer
Via Business Wire
News headline image
Bayer Issues Voluntary Recall Nationwide of VITRAKVI® (larotrectinib) Oral Solution 20 mg/mL Due to Presence of Microbial Contamination
From Bayer
Via Business Wire
News headline image
Bayer Provides Update on Aliqopa® (copanlisib)
From Bayer
Via Business Wire
News headline image
New asundexian Phase III study to include patients with atrial fibrillation ineligible for oral anticoagulant treatment
From Bayer
Via Business Wire
News headline image
Bayer and Recursion focus research collaboration on Oncology
From Bayer
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story